Key Financial Performance Amid Industry Headwinds
Highmark Health reported $29.4 billion in revenue for 2024, alongside $50 million in net income as the healthcare organization continues to navigate significant industry challenges. Despite the positive revenue figures, the company disclosed $209 million in operating losses, primarily attributed to performance issues within its health plans division.
The financial results, released last week, highlight the ongoing struggle many health insurers face in the current economic and healthcare landscape. Cost pressures remained persistent throughout the year, creating a challenging operational environment for the organization.
Bright Spots in Dental and Stop-Loss Divisions
Despite overall challenges, certain segments of Highmark’s business demonstrated resilience. United Concordia Dental and HM Insurance Group, the company’s specialized stop-loss division, emerged as financial bright spots with steady performance throughout the reporting period.
The company attributes this positive trend to strategic growth in dental membership and implementing a disciplined pricing approach that helped maintain profitability in these divisions while other segments faced difficulties.
Allegheny Health Network Shows Positive Growth
The Allegheny Health Network (AHN), Highmark’s integrated health system, demonstrated notable improvements with increased patient volumes across all service areas. This growth represents a significant achievement in the competitive healthcare provider landscape.
Through December 31, AHN recorded a 3% increase in inpatient discharges and observations compared to year-end 2023. Outpatient registrations showed even stronger growth at 6%, while physician visits and emergency room utilization both increased by 5% year-over-year.
Addressing Major Healthcare Cost Challenges
Carl Daley, Chief Financial Officer and Treasurer of Highmark Health, identified several specific challenges affecting performance:
“While our consolidated revenue improved, we continue to face significant industry headwinds and medical cost trends, including high costs for prescription drugs, especially GLP-1s, the impact of Medicaid redeterminations and nationwide high utilization, especially within the Medicare Advantage portfolio,” Daley explained.
Despite these obstacles, leadership remains confident in the organization’s ability to navigate the difficult landscape. “We expect these industrywide challenges to continue, but our comprehensive strategies and strong financial position will allow us to navigate these difficulties while financing and powering our transformational strategy,” Daley added. “We’re built for this and well-prepared to weather this challenging environment.”
Membership Growth and Strategic Direction
Despite financial pressures, Highmark’s insurance division reported positive membership growth. By January 2025, total membership reached 7.1 million, representing an increase from the previous year.
CEO David Holmberg emphasized the company’s continued focus on its Living Health strategy, particularly highlighting the collaboration between Highmark’s insurance arm and AHN on value-based care initiatives in western Pennsylvania. This partnership has reportedly delivered improvements in both patient satisfaction and clinical outcomes while helping to better manage healthcare costs.
Future Healthcare Sustainability
Holmberg articulated the company’s vision for addressing broader industry challenges: “Our industry needs a more economically sustainable approach that delivers better health experiences and outcomes. That is exactly the challenge we’ve taken on with our long-term transformational strategy and Living Health model.”
The company remains committed to its transformation efforts despite the difficult operating environment, positioning itself to adapt to evolving healthcare market dynamics while pursuing its strategic priorities.
Discover the latest payers’ news updates with a single click. Follow DistilINFO HealthPlan and stay ahead with updates. Join our community today!
